Health Rona Therapeutics Reveals Promising Phase 1 Data for RN0361 in New Orleans Rona Therapeutics showcased significant Phase 1 clinical data for its investigational drug, RN0361, during the American Heart Association conference in New Orleans on November... Editorial5 hours ago